Report Summary
Eternity Insights has published a new study on Global Intramuscular Injector Market focusing on key segments as by Type (Pre-fillable Injection System,Fillable Needle-free Injectors, Other), by Application (Hospitals,Clinics,Ambulatory Surgery Centers,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Intramuscular Injector Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Intramuscular Injector Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Intramuscular Injector Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Intramuscular Injector Market Segmentation:
Intramuscular Injector Market, By Type
- Pre-fillable Injection System
- Fillable Needle-free Injectors
- Other
Intramuscular Injector Market, By Application
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Intramuscular Injector market in terms of demand generation. The Intramuscular Injector market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Intramuscular Injector market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Intramuscular Injector Market Taxonomy:
To learn more about this report
Global Intramuscular Injector Market Competitive Landscape
The global Intramuscular Injector market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Antares Pharma
- Endo International Plc
- Bioject Medical Technologies
- PharmaJetMedical International Technology
- National Medical Products
- Valeritas
- European Pharma Group
- PenJet Corporation
- Becton
- Dickinson
- Injex Pharma AG
- Crossject SA
- Solace Biotech
- Sanify Healthcare Private Limited
- Novosanis
- Vata
- Kaleo
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Pre-fillable Injection System,Fillable Needle-free Injectors, Other |
| By Application Outlook |
Hospitals,Clinics,Ambulatory Surgery Centers,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Antares Pharma,Endo International Plc,Bioject Medical Technologies,PharmaJetMedical International Technology,National Medical Products,Valeritas,European Pharma Group,PenJet Corporation,Becton,Dickinson,Injex Pharma AG,Crossject SA,Solace Biotech,Sanify Healthcare Private Limited,Novosanis,Vata,Kaleo |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Intramuscular Injector Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Intramuscular Injector Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Pre-fillable Injection System Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Fillable Needle-free Injectors Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Intramuscular Injector Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Intramuscular Injector Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Intramuscular Injector Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Intramuscular Injector Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Intramuscular Injector Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Intramuscular Injector Market Assessment by Type
8.1 Asia Pacific Intramuscular Injector Market Assessment by Application (Consumption and Market Share)
8.2 North America Intramuscular Injector Market Assessment by Application (Consumption and Market Share)
8.3 Europe Intramuscular Injector Market Assessment by Application (Consumption and Market Share)
8.4 South America Intramuscular Injector Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Intramuscular Injector Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Antares Pharma
9.1.1 Antares Pharma Profiles
9.1.2 Antares Pharma Product Portfolio
9.1.3 Antares Pharma Intramuscular Injector Business Performance
9.1.4 Antares Pharma Intramuscular Injector Business Development and Market Status
9.2 Endo International Plc
9.2.1 Endo International Plc Profiles
9.2.2 Endo International Plc Product Portfolio
9.2.3 Endo International Plc Intramuscular Injector Business Performance
9.2.4 Endo International Plc Intramuscular Injector Business Development and Market Status
9.3 Bioject Medical Technologies
9.3.1 Bioject Medical Technologies Profiles
9.3.2 Bioject Medical Technologies Product Portfolio
9.3.3 Bioject Medical Technologies Intramuscular Injector Business Performance
9.3.4 Bioject Medical Technologies Intramuscular Injector Business Development and Market Status
9.4 PharmaJetMedical International Technology
9.4.1 PharmaJetMedical International Technology Profiles
9.4.2 PharmaJetMedical International Technology Product Portfolio
9.4.3 PharmaJetMedical International Technology Intramuscular Injector Business Performance
9.4.4 PharmaJetMedical International Technology Intramuscular Injector Business Development and Market Status
9.5 National Medical Products
9.5.1 National Medical Products Profiles
9.5.2 National Medical Products Product Portfolio
9.5.3 National Medical Products Intramuscular Injector Business Performance
9.5.4 National Medical Products Intramuscular Injector Business Development and Market Status
9.6 Valeritas
9.6.1 Valeritas Profiles
9.6.2 Valeritas Product Portfolio
9.6.3 Valeritas Intramuscular Injector Business Performance
9.6.4 Valeritas Intramuscular Injector Business Development and Market Status
9.7 European Pharma Group
9.7.1 European Pharma Group Profiles
9.7.2 European Pharma Group Product Portfolio
9.7.3 European Pharma Group Intramuscular Injector Business Performance
9.7.4 European Pharma Group Intramuscular Injector Business Development and Market Status
9.8 PenJet Corporation
9.8.1 PenJet Corporation Profiles
9.8.2 PenJet Corporation Product Portfolio
9.8.3 PenJet Corporation Intramuscular Injector Business Performance
9.8.4 PenJet Corporation Intramuscular Injector Business Development and Market Status
9.9 Becton
9.9.1 Becton Profiles
9.9.2 Becton Product Portfolio
9.9.3 Becton Intramuscular Injector Business Performance
9.9.4 Becton Intramuscular Injector Business Development and Market Status
9.10 Dickinson
9.10.1 Dickinson Profiles
9.10.2 Dickinson Product Portfolio
9.10.3 Dickinson Intramuscular Injector Business Performance
9.10.4 Dickinson Intramuscular Injector Business Development and Market Status
9.11 Injex Pharma AG
9.12 Crossject SA
9.13 Solace Biotech
9.14 Sanify Healthcare Private Limited
9.15 Novosanis
9.16 Vata
9.17 Kaleo
10 World Intramuscular Injector Market Assessment by Players
10.1 Global Intramuscular Injector Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Intramuscular Injector Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Intramuscular Injector Price (USD/Unit) of Players 2014-2020
10.4 Global Intramuscular Injector Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Intramuscular Injector Sales Assessment of Players 2014-2020
11.1.2 North America Intramuscular Injector Revenue Assessment of Players 2014-2020
11.1.3 North America Intramuscular Injector Price Assessment of Players 2014-2020
11.1.4 North America Intramuscular Injector Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Intramuscular Injector Sales Assessment of Players 2014-2020
11.2.2 Europe Intramuscular Injector Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Intramuscular Injector Price Assessment of Players 2014-2020
11.2.4 Europe Intramuscular Injector Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Intramuscular Injector Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Intramuscular Injector Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Intramuscular Injector Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Intramuscular Injector Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Intramuscular Injector Sales Assessment of Players 2014-2020
11.4.2 South America Intramuscular Injector Revenue Assessment of Players 2014-2020
11.4.3 South America Intramuscular Injector Price Assessment of Players 2014-2020
11.4.4 South America Intramuscular Injector Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Intramuscular Injector Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Intramuscular Injector Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Intramuscular Injector Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Intramuscular Injector Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Intramuscular Injector Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Intramuscular Injector Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Intramuscular Injector Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Intramuscular Injector Sales by Countries/Regions 2014-2020
12.2.2 North America Intramuscular Injector Revenue by Countries/Regions 2014-2020
12.2.3 North America Intramuscular Injector Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Intramuscular Injector Sales by Countries/Regions 2014-2020
12.3.2 Europe Intramuscular Injector Revenue by Countries/Regions 2014-2020
12.3.3 Europe Intramuscular Injector Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Intramuscular Injector Sales by Countries/Regions 2014-2020
12.4.2 South America Intramuscular Injector Revenue by Countries/Regions 2014-2020
12.4.3 South America Intramuscular Injector Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Intramuscular Injector Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Intramuscular Injector Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Intramuscular Injector Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Intramuscular Injector Sales & Revenue Forecast 2021-2026
14.1 World Intramuscular Injector Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Intramuscular InjectorSales and Market Share by Regions
14.1.2 World Intramuscular InjectorRevenue and Market Share by Regions
15 Asia Intramuscular Injector Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Pre-fillable Injection System
15.1.2 Fillable Needle-free Injectors
15.2 Consumption Forecast by Application, 2021-2026
16 North America Intramuscular Injector Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Pre-fillable Injection System
16.1.2 Fillable Needle-free Injectors
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Intramuscular Injector Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Pre-fillable Injection System
17.1.2 Fillable Needle-free Injectors
17.2 Consumption Forecast by Application, 2021-2026
18 South America Intramuscular Injector Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Pre-fillable Injection System
18.1.2 Fillable Needle-free Injectors
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Intramuscular Injector Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Pre-fillable Injection System
19.1.2 Fillable Needle-free Injectors
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Intramuscular Injector Price (USD/Unit) Trend 2021-2026
20.2 Global Intramuscular Injector Gross Profit Trend 2021-2026
21 Conclusion
